The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMulberry Group Regulatory News (MUL)

Share Price Information for Mulberry Group (MUL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 112.50
Bid: 105.00
Ask: 120.00
Change: -5.00 (-4.55%)
Spread: 15.00 (14.286%)
Open: 110.00
High: 105.00
Low: 105.00
Prev. Close: 110.00
MUL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grants under Deferred Bonus Plan

6 Jul 2012 15:09

RNS Number : 1457H
Mulberry Group PLC
06 July 2012
 



Mulberry Group plc

 

Grants under Deferred Bonus Plan, Issue of new Ordinary Shares and Transfer of Shares

 

Grants under Deferred Bonus Plan and Issue of new Ordinary Shares

 

On 1 July 2012 Mulberry Group plc ("Mulberry" or "the Company") granted awards of deferred ordinary shares of 5 pence each in the Company ("Ordinary Shares") under Mulberry's Deferred Bonus Plan at a price of 1,475.5 pence per Ordinary Share. These grants relate to bonus payments awarded to the Executive Directors and other key employees in respect of the Company's performance for the financial year ended 31 March 2012. The deferred Ordinary Shares, which are held within the Mulberry Group plc Employee Benefit Trust ("the Trust"), will vest on 1 July 2014.

 

The total number of Ordinary Shares subject to these grants is as follows:

 

Name

Number of deferred Ordinary Shares granted under Deferred Bonus Plan

Roger Mather

3,253

Other key employees

21,862

Total

25,115

 

In addition to the grant of deferred Ordinary Shares under the deferred Bonus Plan, a matching number of nil cost options have been awarded. The options in this grant will vest on 1 July 2014 and are exercisable between 1 July 2014 and 1 July 2022.

 

Name

Number of matching nil cost options granted

Roger Mather

3,253

Other key employees

21,862

Total

25,115

 

In order to ensure that the Trust has sufficient shares to cover the awards of deferred Ordinary Shares, the Company has approved the issue of 20,000 new Ordinary Shares to the Trust.

 

Application has been made to the London Stock Exchange for the new Ordinary Shares to be admitted to AIM and it is expected that admission will take place on 12 July 2012.

 

Transfer of shares

 

Following vesting of earlier deferred interests under Mulberry's Deferred Bonus Plan, a number of Ordinary Shares have been transferred from the Trust to certain Directors as follows:

 

Name

Number of Ordinary Shares transferred from the Trust

Roger Mather

19,768

Godfrey Davis

24,330

 

Following these transactions;

 

Roger Mather's beneficial interest in the Company consists of 32,166 Ordinary Shares representing 0.05% of the Company's issued Ordinary Shares. Roger Mather also holds rights over 250,000 Ordinary Shares under Mulberry's Co-Ownership Plan, 10,449 unvested deferred Ordinary Shares, 10,449 unvested matching nil cost options and 19,768 vested nil cost options all under the Company's Deferred Bonus Plan.

 

Godfrey Davis' beneficial interest in the Company consists of 713,490 Ordinary Shares representing 1.20% of the Company's issued Ordinary Shares. Godfrey Davis also holds rights over 300,000 Ordinary Shares under Mulberry's Co-Ownership Plan, 5,037 unvested deferred Ordinary Shares, 5,037 unvested matching nil cost options, 24,330 vested nil cost options all under the Company's Deferred Bonus Plan and 90,000 options under the Company's 2008 Unapproved Share Option Scheme.

 

Total Voting Rights

 

The issued share capital of the Company following admission of the new Ordinary Shares will be 59,655,175 Ordinary Shares with a nominal value of 5 pence each. No Ordinary Shares are held in treasury. Therefore, the total number of voting rights in Mulberry is 59,655,175.

 

The figure of 59,655,175 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

Enquiries:

 

Pelham Bell Pottinger

Dan de Belder / Julia Hanrahan

0207 861 3232

Altium

Ben Thorne / Katherine Hobbs

0207 484 4040

Barclays Capital

Jon Bathard-Smith / Nicola Tennent

0203 134 9803

Mulberry Investor Relations

Amelia Fincher

0207 605 6771

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCRFMJTMBAMBJT
Date   Source Headline
1st May 20247:00 amRNSYear End Trading Update
6th Feb 20249:42 amRNSDirectors Dealing
22nd Jan 20247:00 amRNSAppointment of Corporate Broker
17th Jan 20247:00 amRNSTrading Update
30th Nov 20237:00 amRNSHalf Year Results
25th Sep 20235:19 pmRNSDirectors Dealing
7th Sep 20232:11 pmRNSResult of AGM
23rd Aug 20237:00 amRNSAppointment ofl Independent Non-Executive Director
4th Aug 20237:00 amRNSPosting of Annual Report and Notice of AGM
19th Jul 20237:00 amRNSGrant under 2008 Unapproved Share Option Scheme
28th Jun 20237:00 amRNSPreliminary results
22nd Jun 20237:00 amRNSAudited FY23 Results - revised announcement date
20th Apr 20237:00 amRNSYear End Trading Update
30th Nov 20229:05 amRNSSecond Price Monitoring Extn
30th Nov 20229:00 amRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf Year Results
17th Nov 20224:41 pmRNSSecond Price Monitoring Extn
17th Nov 20224:35 pmRNSPrice Monitoring Extension
7th Sep 202212:22 pmRNSAGM Statement
23rd Aug 20227:00 amRNSDirectorate Changes
3rd Aug 20229:11 amRNSAnnual Report and notice of General Meeting
11th Jul 20227:00 amRNSDirector/PDMR Shareholding
6th Jul 20222:08 pmRNSReplacement: Director/PDMR Shareholding
5th Jul 20225:53 pmRNSDirector/PDMR Dealing
29th Jun 20227:00 amRNSFinal Results
29th Mar 20227:00 amRNSTrading Update and notice of Full Year Results
9th Mar 20222:01 pmRNSPrice Monitoring Extension
24th Nov 20217:00 amRNSHalf-year Report
8th Sep 20213:11 pmRNSResult of AGM
11th Aug 20215:09 pmRNSAnnual Financial Report and Notice of AGM
21st Jul 20217:00 amRNSAnnual Financial Report
6th Jul 20217:01 amRNSEarly exit of Paris lease
28th Apr 20217:00 amRNSTrading Update
20th Apr 20217:00 amRNSLaunch of New Sustainability Manifesto
17th Feb 20219:02 amRNSAward of shares to CEO
18th Dec 20207:00 amRNSStatement regarding Frasers Group plc
17th Dec 20203:42 pmRNSNo intention to bid statement: Mulberry Group plc
2nd Dec 20206:00 pmRNSForm 8 (OPD) (Mulberry Group Plc)
1st Dec 20208:44 amRNSForm 8 (OPD) – Mulberry Group plc
27th Nov 202011:45 amBUSFORM 8.5 (EPT/NON-RI) - MULBERRY GROUP PLC
26th Nov 20207:00 amRNSResults for the 26 weeks ended 26 September 2020
25th Nov 202010:42 amBUSFORM 8.5 (EPT/NON-RI) - MULBERRY GROUP PLC
23rd Nov 20209:14 amBUSFORM 8.5 (EPT/NON-RI) - MULBERRY GROUP PLC
20th Nov 202012:27 pmBUSForm 8.5 (EPT/NON-RI) - Mulberry Group plc
20th Nov 202011:38 amRNSNotification of major holdings
20th Nov 20207:00 amRNSCommencement of Offer Period
19th Nov 202012:56 pmRNSNotification of major holdings
19th Nov 20209:18 amRNSAcquisition of Shares and Dispensation from Rule 9
17th Nov 202012:43 pmRNSResult of General Meeting
13th Nov 20208:24 amRNSAppointment of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.